News & Breakthroughs at Siteman
Stay informed with the latest cancer news and breakthroughs from Siteman Cancer Center. Our news feed provides timely updates on research breakthroughs, clinical trials, and community events.
In the Media
Siteman Cancer Center unveils new, state-of-the-art mammography van
Mobile mammography services continue to move forward in the St. Louis region with unveiling of Siteman Cancer Center’s new mammography van. Equipped with high-resolution 3-D digital technology, the van provides the same advanced imaging that patients receive at Siteman’s four St. Louis area mammography clinics. Washington University radiologists who specialize in breast imaging read all […]
In the Media
Laser surgery opens blood-brain barrier to chemotherapy
Using a laser probe, neurosurgeons at Washington University School of Medicine in St. Louis have opened the brain’s protective cover, enabling them to deliver chemotherapy drugs to patients with a form of deadly brain cancer. In a pilot study, 14 patients with glioblastoma – the most common and aggressive type of brain cancer – underwent […]
Staff/Faculty Update
Govindan named Anheuser-Busch Endowed Chair in Medical Oncology
Ramaswamy Govindan, MD, has been named the Anheuser-Busch Endowed Chair in Medical Oncology at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis. The Anheuser-Busch Foundation established the endowed chair in 2001 through The Foundation for Barnes-Jewish Hospital. Govindan was honored for his innovative research, including in genomics, aimed at developing better lung cancer therapies […]
In the Media
Washington University leads national effort to improve radiation therapy for U.S. veterans
Washington University School of Medicine in St. Louis has been selected to lead national efforts to improve and standardize radiation therapy for veterans with cancer. The goal is to ensure that veterans across the U.S. receive the same high-quality radiation therapy at any of the 40 Veterans Health Administration (VHA) radiation oncology centers nationwide. Working […]
Staff/Faculty Update
Mardis visits White House to discuss cancer research
Elaine Mardis, PhD, co-director of The McDonnell Genome Institute at Washington University School of Medicine in St. Louis, joined a group of 14 other distinguished cancer researchers and physician-scientists Jan. 8 at the White House to talk with Vice President Joseph Biden’s staff about his “moonshot” challenge to cure cancer. The researchers, convened by the […]
Staff/Faculty Update
Goodman appointed to City of St. Louis Board of Health and Hospitals
Melody Goodman, PhD, an assistant professor of surgery at Washington University School of Medicine and a research member of Siteman Cancer Center, has been appointed to the City of St. Louis Board of Health and Hospitals. Mayor Francis Slay appointed Goodman, who will serve until 2019. In the role, she will advise the city health […]
Research
Some deadly breast cancers share genetic features with ovarian tumors
The most comprehensive analysis yet of breast cancer shows that one of the most deadly subtypes is genetically more similar to ovarian tumors than to other breast cancers. The findings, published online Sept. 23 in Nature, suggest that most basal-like breast tumors and ovarian tumors have similar genetic origins and potentially could be treated with […]
Research
Special glasses help surgeons ‘see’ cancer
High-tech glasses developed at Washington University School of Medicine in St. Louis may help surgeons visualize cancer cells, which glow blue when viewed through the eyewear. The wearable technology, so new it’s yet unnamed, was used during surgery for the first time Feb. 10, 2014 at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School […]
Clinical, Research
Breast cancer vaccine shows promise in small clinical trial
A breast cancer vaccine developed at Washington University School of Medicine in St. Louis is safe in patients with metastatic breast cancer, results of an early clinical trial indicate. Preliminary evidence also suggests that the vaccine primed the patients’ immune systems to attack tumor cells and helped slow the cancer’s progression. The study appears Dec. 1 […]
In the Media
Personalized melanoma vaccines marshal powerful immune response
Personalized melanoma vaccines can be used to marshal a powerful immune response against unique mutations in patients’ tumors, according to early data in a first-in-people clinical trial at Washington University School of Medicine in St. Louis. The tailor-made vaccines, given to three patients with advanced melanoma, appeared to increase the number and diversity of cancer-fighting […]